Baiji Hongye

Beijing Baiji Hongye Pharmaceutical Technology is a specialized pharmaceutical research and development company based in Beijing, China. Founded in 2004, the company provides a range of technical services including drug synthesis, process optimization, and technology transfer for both chemical and biological medicines. They focus on the development of generic drugs and improved new drugs, offering CMC (Chemistry, Manufacturing, and Controls) services to pharmaceutical manufacturers. The company holds several patents related to the synthesis of active pharmaceutical ingredients (APIs) such as Rivaroxaban and Ticagrelor, as well as vaccine adjuvants and natural product extraction. Baiji Hongye primarily serves the domestic Chinese market, supporting the optimization of production processes for established therapies.